Mark Bayliss

1.0k total citations
46 papers, 835 citations indexed

About

Mark Bayliss is a scholar working on Spectroscopy, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark Bayliss has authored 46 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Spectroscopy, 9 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Mark Bayliss's work include Mass Spectrometry Techniques and Applications (10 papers), Analytical Chemistry and Chromatography (8 papers) and Urinary Bladder and Prostate Research (8 papers). Mark Bayliss is often cited by papers focused on Mass Spectrometry Techniques and Applications (10 papers), Analytical Chemistry and Chromatography (8 papers) and Urinary Bladder and Prostate Research (8 papers). Mark Bayliss collaborates with scholars based in United Kingdom, United States and France. Mark Bayliss's co-authors include Christopher Fry, Donald Newgreen, Anthony R. Mundy, Changhao Wu, B. Kevin Park, Jan Snoeys, Laleh Kamalian, Amy E. Chadwick, Neil French and Mario Monshouwer and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Urology and Journal of Chromatography A.

In The Last Decade

Mark Bayliss

45 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bayliss United Kingdom 12 280 239 85 85 83 46 835
Takao Yamamoto Japan 19 354 1.3× 263 1.1× 137 1.6× 17 0.2× 102 1.2× 66 941
Shridhar Narayanan India 17 48 0.2× 542 2.3× 22 0.3× 51 0.6× 98 1.2× 52 1.1k
Hidenori Mochizuki Japan 23 37 0.1× 531 2.2× 53 0.6× 21 0.2× 65 0.8× 72 1.4k
Adree Khondker Canada 19 113 0.4× 334 1.4× 16 0.2× 58 0.7× 55 0.7× 73 871
Bin Ji China 19 31 0.1× 639 2.7× 62 0.7× 222 2.6× 61 0.7× 52 1.1k
Atsushi Kitamura Japan 20 38 0.1× 493 2.1× 50 0.6× 42 0.5× 176 2.1× 105 1.4k
Ameneh Jafari Iran 19 22 0.1× 451 1.9× 13 0.2× 63 0.7× 36 0.4× 49 1.1k
Ewoud J. van Hoogdalem Netherlands 16 28 0.1× 295 1.2× 22 0.3× 21 0.2× 104 1.3× 39 981
Hisashi Takahashi Japan 18 14 0.1× 371 1.6× 17 0.2× 28 0.3× 108 1.3× 67 1.5k
Hohyun Kim South Korea 22 19 0.1× 393 1.6× 41 0.5× 43 0.5× 83 1.0× 103 1.6k

Countries citing papers authored by Mark Bayliss

Since Specialization
Citations

This map shows the geographic impact of Mark Bayliss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bayliss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bayliss more than expected).

Fields of papers citing papers by Mark Bayliss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bayliss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bayliss. The network helps show where Mark Bayliss may publish in the future.

Co-authorship network of co-authors of Mark Bayliss

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bayliss. A scholar is included among the top collaborators of Mark Bayliss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bayliss. Mark Bayliss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arnold, David, Fergus Hamilton, Jessica Hughes, et al.. (2024). Antibiotic pharmacokinetics in infected pleural effusions. Thorax. 79(9). 883–885. 3 indexed citations
2.
Luque, Sònia, William Hope, Antigone Kotsaki, et al.. (2024). Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA. Journal of Antimicrobial Chemotherapy. 79(12). 3303–3312. 2 indexed citations
4.
MacGowan, Alasdair, Fergus Hamilton, Mark Bayliss, et al.. (2021). Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2. Journal of Global Antimicrobial Resistance. 24. 178–179. 3 indexed citations
5.
Rawson, Timothy M., Sally A. N. Gowers, David M E Freeman, et al.. (2019). Microneedle biosensors for real-time, minimally invasive drug monitoring of phenoxymethylpenicillin: a first-in-human evaluation in healthy volunteers. The Lancet Digital Health. 1(7). e335–e343. 131 indexed citations
6.
Bayliss, Mark, et al.. (2019). Development, validation and application of a novel HPLC-MS/MS method for the measurement of minocycline in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 169. 90–98. 17 indexed citations
7.
Bayliss, Mark, et al.. (2019). Challenges in the bioanalysis of tetracyclines: Epimerisation and chelation with metals. Journal of Chromatography B. 1134-1135. 121807–121807. 13 indexed citations
8.
Kamalian, Laleh, Amy E. Chadwick, Mark Bayliss, et al.. (2015). The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death. Toxicology in Vitro. 29(4). 732–740. 116 indexed citations
10.
11.
Harper, Alex, et al.. (2008). Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan. Age and Ageing. 37(6). 719–720. 4 indexed citations
12.
Newton, Russell P., Christopher J. Smith, Terence J. Walton, et al.. (2001). Variation in isomeric products of a phosphodiesterase from the chloroplasts of Phaseolus vulgaris in response to cations. Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology. 135(2). 143–156. 3 indexed citations
13.
Bayliss, Mark, et al.. (1999). A quantitative study of atropine-resistant contractions in human detrusor smooth muscle, from stable, unstable and obstructed bladders. UCL Discovery (University College London). 11 indexed citations
14.
Newton, Russell P., Mark Bayliss, Jalaluddin A. Khan, et al.. (1999). Kinetic analysis of cyclic CMP-specific and multifunctional phosphodiesterases by quantitative positive-ion fast-atom bombardment mass spectrometry. Rapid Communications in Mass Spectrometry. 13(7). 574–584. 22 indexed citations
15.
Bayliss, Mark, Donald Newgreen, & CH Fry. (1998). Changes to the functional properties of human detrusor smooth muscle and its innervation with disease. UCL Discovery (University College London). 1 indexed citations
16.
Walton, Terence J., Mark Bayliss, David E. Games, et al.. (1998). Fast-atom bombardment tandem mass spectrometry of cyclic nucleotide analogues used as site-selective activators of cyclic nucleotide-dependent protein kinases. Rapid Communications in Mass Spectrometry. 12(8). 449–455. 4 indexed citations
17.
Fry, CH, et al.. (1997). Detrusor relaxation of the normal and pathological bladder. UCL Discovery (University College London). 2 indexed citations
18.
Newton, Russell P., et al.. (1997). Kinetic analysis and multiple component monitoring of effectors of adenylyl cyclase activity by quantitative fast-atom bombardment mass spectrometry. Rapid Communications in Mass Spectrometry. 11(9). 1060–1066. 5 indexed citations
19.
Baker, Paul R.S., Mark Bayliss, & David J. Wilkinson. (1997). Determination of a major metabolite of tipredane in rat urine by high-performance liquid chromatography with column switching. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 193–198. 2 indexed citations
20.
Bayliss, Mark, Paul R.S. Baker, & David J. Wilkinson. (1997). Determination of the two major human metabolites of tipredane in human urine by high-performance liquid chromatography with column switching. Journal of Chromatography B Biomedical Sciences and Applications. 694(1). 199–209. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026